These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31509441)

  • 21. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
    Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
    AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
    Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
    Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
    Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
    Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
    da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound (CEUS) as a follow-up method after the focal treatment of renal tumors: systematic review and meta-analysis.
    Vovdenko S; Ali S; Ali H; Taratkin M; Morozov A; Suvorov A; Khabib D; Rapoport L; Bezrukov E
    Int Urol Nephrol; 2024 Nov; 56(11):3415-3426. PubMed ID: 38851652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation.
    Bo XW; Xu HX; Sun LP; Zheng SG; Guo LH; Lu F; Wu J; Xu XH
    Int J Clin Exp Pathol; 2014; 7(9):6108-16. PubMed ID: 25337258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
    Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
    Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
    Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
    Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
    Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
    Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis.
    Xuan M; Zhou F; Ding Y; Zhu Q; Dong J; Zhou H; Cheng J; Jiang X; Wu P
    Surg Endosc; 2018 Apr; 32(4):2067-2075. PubMed ID: 29270801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.
    Zheng SG; Xu HX; Lu MD; Xie XY; Xu ZF; Liu GJ; Liu LN
    World J Gastroenterol; 2013 Feb; 19(6):855-65. PubMed ID: 23430451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.